This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zehbe, I. Articles by Tommasino, M. Search for Related Content PubMed PubMed Citation Articles by Zehbe, I. Articles by Tommasino, M.

p53 Codon 72 Polymorphism and Various Human Papillomavirus 16 E6 Genotypes Are Risk Factors for Cervical Cancer Development¹

Angewandte Tumorvirologie [I. Z., F. K., M. T.], Abteilung für Oligosynthese und Sequenzierung [H. D.], Abteilung für Biostatistik [L. E.], Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany; Servizio di Anatomia Patologica, Ospedale Sant’ Anna, 10126 Torino, Italy [G. V., A. M.], and Department of Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden [E. W., S. A.]

Risk factors other than human papillomavirus (HPV) infection per se for cervical cancer development have been investigated recently. It was suggested that HPV 16 E6 variants and the p53 codon 72 arginine polymorphism could be progression markers. Indeed, it has been demonstrated that specific E6 variants and p53 arginine were both enriched in cancer. However, especially with regard to the latter, divergent results have been reported. Our aim was thus to investigate whether p53 arginine is important for cervical carcinogenesis by scaling up samples of the two European cohorts, the initial results of which were reported previously. In addition, we have assessed the occurrence of p53 codon 72 arginine, in combination with specific HPV 16 E6 genotypes. We found p53 arginine to be increased in cancer of both cohorts, consistent with our previous concept. Although specific E6 genotypes increased gradually with the severity of the lesion, p53 arginine was enriched in cancer only. Moreover, the frequency of the arginine allele was similar in groups with different E6 genotypes. It is concluded that p53 arginine is a risk factor for cervical cancer but probably acts independently of E6 variants.

This article has been cited by other articles:

				N. Jain, V. Singh, S. Hedau, S. Kumar, M. K. Daga, R. Dewan, N. S. Murthy, S. A. Husain, and B. C. Das Infection of Human Papillomavirus Type 18 and p53 Codon 72 Polymorphism in Lung Cancer Patients From India Chest, December 1, 2005; 128(6): 3999 - 4007. [Abstract] [Full Text] [PDF]

				N. F. Schlecht, R. D. Burk, J. M. Palefsky, H. Minkoff, X. Xue, L. S. Massad, M. Bacon, A. M. Levine, K. Anastos, S. J. Gange, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women J. Gen. Virol., October 1, 2005; 86(10): 2709 - 2720. [Abstract] [Full Text] [PDF]

				J. Tommiska, H. Eerola, M. Heinonen, L. Salonen, M. Kaare, J. Tallila, A. Ristimaki, K. von Smitten, K. Aittomaki, P. Heikkila, et al. Breast Cancer Patients with p53 Pro72 Homozygous Genotype Have a Poorer Survival Clin. Cancer Res., July 15, 2005; 11(14): 5098 - 5103. [Abstract] [Full Text] [PDF]

				S Mitra, C Misra, R K Singh, C K Panda, and S Roychoudhury Association of specific genotype and haplotype of p53 gene with cervical cancer in India J. Clin. Pathol., January 1, 2005; 58(1): 26 - 31. [Abstract] [Full Text] [PDF]

				D. Lattuada, P. Vigano, E. Somigliana, A. Abbiati, M. Candiani, and A.M. Di Blasio Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis Mol. Hum. Reprod., September 1, 2004; 10(9): 651 - 654. [Abstract] [Full Text] [PDF]

				A. K. Chaturvedi, J. A. Brinkman, A. M. Gaffga, J. Dumestre, R. A. Clark, P. S. Braly, K. Dunlap, P. J. Kissinger, and M. E. Hagensee Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women J. Gen. Virol., May 1, 2004; 85(5): 1237 - 1241. [Abstract] [Full Text] [PDF]

				R. Schneider-Stock, C. Mawrin, C. Motsch, C. Boltze, B. Peters, R. Hartig, P. Buhtz, A. Giers, A. Rohrbeck, B. Freigang, et al. Retention of the Arginine Allele in Codon 72 of the p53 Gene Correlates with Poor Apoptosis in Head and Neck Cancer Am. J. Pathol., April 1, 2004; 164(4): 1233 - 1241. [Abstract] [Full Text] [PDF]

				A. Koushik, R. W. Platt, and E. L. Franco p53 Codon 72 Polymorphism and Cervical Neoplasia: A Meta-Analysis Review Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 11 - 22. [Abstract] [Full Text] [PDF]

				A-M Martin, P A Kanetsky, B Amirimani, T A Colligon, G Athanasiadis, H A Shih, M R Gerrero, K Calzone, T R Rebbeck, and B L Weber Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? J. Med. Genet., April 1, 2003; 40(4): e34 - 34. [Full Text] [PDF]

				M. Furihata, T. Takeuchi, M. Matsumoto, A. Kurabayashi, Y. Ohtsuki, N. Terao, M. Kuwahara, and T. Shuin p53 Mutation Arising in Arg72 Allele in the Tumorigenesis and Development of Carcinoma of the Urinary Tract Clin. Cancer Res., May 1, 2002; 8(5): 1192 - 1195. [Abstract] [Full Text] [PDF]

				F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265. [Abstract] [Full Text] [PDF]